Per some interview with some Chinese doctors who battled COVID19, they said that for many critical patients, their viral load is actually low, but the virus had caused damages to all parts of their bodies thus antiviral isn't going to do anything significant at that stage.
This might suggest chloroquine could be helpful at earlier stage of COVID19, to help prevent patients developing into server/critical stage, which would still be a very good thing if hold true.
I believe with the number of patients they have, they would've updated the guideline if it wasn't effective at all. But how effective it is we don't know. If a large percentage of some areas is already infected but the health system is still in the state it's in now, it could actually be a good sign. If the current numbers are realistic (which I don't believe at a positive test rate of >30%), it's probably not. We simply cannot know.
> Il trattamento deve essere accompagnato da trattamento antivirale (lopinavir/ritonavir o remdesivir + clorochina/idrossiclorochina) e/o steorideo (desametasone)
This is from the 13th of March so I guess there will be still some days until we see results of this (either positive or negative)
That seems like pretty strong evidence that the new treatment protocol is drastically decelerating the pandemic in Italy.
What are you basing "it has at best a marginal effect" on?
From what I can gather chloroquine is already used as a first line treatment in Italian hospitals (at least it is indicated as such by the COVID treatment guidelines published by the society of Italian infectious disease specialists [0], and has been for quite some time - this document is from 10 days ago, but an earlier revision was not different regarding chloroquine). If this is the case, it's pretty clear that this is no miracle cure - it has at best a marginal effect.
[0] http://www.simit.org/medias/1569-covid19-vademecum-13-03-202...